Currently Viewing:
Supplements Current Treatment Options for Osteoarthritis
The Burden of Osteoarthritis: Clinical and Quality-of-Life Issues
Roland W. Moskowitz, MD
Practical Considerations for the Pharmacologic Management of Osteoarthritis
Roy Davis Altman, MD
The Economic Burden of Osteoarthritis
Ryan Bitton, PharmD, MBA
Currently Reading
Participating Faculty

Participating Faculty

Current Treatment Options for Osteoarthritis

This supplement to The American Journal of Managed Care reviews the economic and clinical implications of osteoarthritis, as well as current treatment options.

 

 
Participating Faculty
Roy Davis Altman, MD
Professor of Medicine
Division of Rheumatology and Immunology
David Geffen School of Medicine
University of California Los Angeles
Los Angeles, California


Ryan Bitton, PharmD, MBA
Manager, Pharmacy Services
Health Plan of Nevada, Inc.
Las Vegas, Nevada


Roland W. Moskowitz, MD
Clinical Professor
Department of Medicine
Case Western Reserve University
Cleveland, Ohio


Faculty Disclosures
Roy Davis Altman, MD
Consultant:
Endo
Ferring
Novartis
Research Grants:
Ferring
Novartis
Lecturer:
Ferring
Forest


Ryan Bitton, PharmD, MBA, and Roland W. Moskowitz, MD, have nothing to disclose.


Funding
This supplement has been supported by funding from Endo Pharmaceuticals.


The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
 
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up